Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 8,845 | $0.75 | 0 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-01 4:38 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:01 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 90,000 | $1.48 | 90,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 4:15 pm | N/A 2032-01-02 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 90,000 | $3.03 | 90,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 4:10 pm | N/A 2031-06-13 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 90,000 | $0 | 90,000 (Direct) | View |